195 related articles for article (PubMed ID: 16441622)
1. A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.
Pacifico A; Daidone R; Peris K
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):153-7. PubMed ID: 16441622
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
Thawornchaisit P; Harncharoen K
J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
[TBL] [Abstract][Full Text] [Related]
5. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.
Barikbin B; Givrad S; Yousefi M; Eskandari F
Clin Exp Dermatol; 2009 Oct; 34(7):776-80. PubMed ID: 19456797
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
Stein L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
Clark RF; Clement ER
Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
[TBL] [Abstract][Full Text] [Related]
8. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
9. Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.
Ortonne JP; Esposito M; Chimenti S; Kapińska-Mrowiecka M; Grodzińska A; Naldi L; Frangione V
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1226-34. PubMed ID: 24256460
[TBL] [Abstract][Full Text] [Related]
10. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
11. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
12. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis.
Weiss SC; Nguyen J; Chon S; Kimball AB
J Drugs Dermatol; 2005; 4(3):339-45. PubMed ID: 15898290
[TBL] [Abstract][Full Text] [Related]
14. Betamethasone plaster: new drug. New pharmaceutical form: just a useless gadget.
Prescrire Int; 2008 Aug; 17(96):144. PubMed ID: 19480099
[TBL] [Abstract][Full Text] [Related]
15. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Gomez EC; Kaminester L; Frost P
Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
[TBL] [Abstract][Full Text] [Related]
16. Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis.
Callen J
Cutis; 1996 Feb; 57(2 Suppl):45-50. PubMed ID: 8646870
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic response to a dermatologic patch and betamethasone valerate 0.1 percent cream in the management of chronic plaques in psoriasis.
Wilkinson RD; Ohayon M
Cutis; 1990 Jun; 45(6):468-70. PubMed ID: 2190758
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
Lee CS; Koo J
J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
[TBL] [Abstract][Full Text] [Related]
20. Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.
Mraz S; Leonardi C; Colón LE; Johnson LA
J Dermatolog Treat; 2008; 19(6):354-9. PubMed ID: 18923991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
